DNA X, Inc. (SONM) Executive Compensation
DNA X, Inc. (SONM) is a publicly traded company on the Nasdaq, categorized under SIC 3661 (Telephone & Telegraph Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SONM
CIK: 1178697
Exchange: Nasdaq
SIC 3661: Telephone & Telegraph Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerKris Dunning
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-31 | 2026-08-28 | 8-K | 0001493152-26-040845 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-21 | 8-K | 0001493152-26-040324 | View SEC Doc Filr Page |
| 10-Q | 2026-08-19 | 2026-06-30 | 10-Q | 0001493152-26-039226 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001493152-26-038320 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-13 | 2026-06-29 | 8-K/A | 0001493152-26-037733 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000935836-26-000396 | View SEC Doc Filr Page |
| 8-K/A | 2026-07-09 | 2026-06-29 | 8-K/A | 0001493152-26-032680 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-29 | 8-K | 0001493152-26-031675 | View SEC Doc Filr Page |
| EFFECT | 2026-06-11 | — | EFFECT Filing | 9999999995-26-001959 | View SEC Doc Filr Page |
| POS AM | 2026-06-08 | — | POS AM | 0001493152-26-027749 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-05-29 | 8-K | 0001493152-26-027295 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-20 | 8-K | 0001493152-26-025433 | View SEC Doc Filr Page |
| 10-Q | 2026-05-20 | 2026-03-31 | 10-Q | 0001493152-26-024644 | View SEC Doc Filr Page |
| 8-K | 2026-05-20 | 2026-05-20 | 8-K | 0001493152-26-024639 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NT 10-Q | 0001493152-26-023793 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000935836-26-000256 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | 10-K/A | 0001493152-26-020421 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-27 | 8-K | 0001493152-26-020414 | View SEC Doc Filr Page |
| 10-K | 2026-04-15 | 2025-12-31 | 10-K | 0001493152-26-016659 | View SEC Doc Filr Page |
| 8-K | 2026-04-15 | 2026-04-14 | 8-K | 0001493152-26-016655 | View SEC Doc Filr Page |
| NT 10-K | 2026-04-01 | 2025-12-31 | NT 10-K | 0001493152-26-014515 | View SEC Doc Filr Page |
| 8-K/A | 2026-03-02 | 2025-12-15 | 8-K/A | 0001493152-26-008444 | View SEC Doc Filr Page |
| 3 | 2026-02-20 | 2025-12-15 | 3 | 0001493152-26-007603 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-02-20 | — | SCHEDULE 13D Filing | 0001493152-26-007602 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0000935836-26-000106 | View SEC Doc Filr Page |